LumiEso Sistema de endoprótesis esofágica

LumiEso Sistema de endoprótesis esofágica

Diseñado con materiales biocompatibles, este avanzado sistema de endoprótesis proporciona apoyo eficaz para estenosis esofágicagarantizando una permeabilidad luminal y mejorado función de deglución en pacientes con obstrucciones esofágicas.

Información

LumiEso Sistema de endoprótesis esofágica is an innovative, autoexpandible stent solution engineered to reestablish y maintain esophageal patency in patients with malignant o benign strictures. Crafted with advanced nitinol or hybrid alloys and featuring precision deployment mechanics, LumiEso stents foster fiable decompression under endoscopic o fluoroscópico guidance—promoting improved ingestion, quality of life, and reducido procedure times in everyday clinical practice.

Key Features & Technology

High-Radial-Force Stent Construction
  • Durable Nitinol/Hybrid Alloy: Supplies continuo radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.
  • Durable Nitinol/Hybrid Alloy: Supplies continuo radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.

Clinical Applications & Benefits

Malignant & Benign Strictures
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.

Productos relacionados